Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$13.58 - $17.36 $58,394 - $74,648
4,300 Added 8.65%
54,000 $849,000
Q4 2023

Feb 14, 2024

SELL
$10.11 - $16.54 $3,467 - $5,673
-343 Reduced 0.69%
49,700 $801,000
Q3 2022

Nov 15, 2022

BUY
$12.38 - $20.23 $4,246 - $6,938
343 Added 0.69%
50,043 $926,000
Q1 2022

May 13, 2022

SELL
$6.87 - $11.11 $37,785 - $61,105
-5,500 Reduced 9.96%
49,700 $461,000
Q2 2021

Jul 30, 2021

SELL
$32.73 - $47.95 $63.4 Million - $92.9 Million
-1,937,506 Reduced 97.23%
55,200 $2.02 Million
Q1 2021

May 06, 2021

BUY
$40.39 - $56.73 $19.7 Million - $27.7 Million
487,445 Added 32.38%
1,992,706 $89.4 Million
Q4 2020

Feb 08, 2021

SELL
$51.77 - $66.18 $2.05 Million - $2.62 Million
-39,575 Reduced 2.56%
1,505,261 $85.9 Million
Q3 2020

Nov 12, 2020

BUY
$43.8 - $58.16 $8.4 Million - $11.2 Million
191,759 Added 14.17%
1,544,836 $79.3 Million
Q2 2020

Aug 13, 2020

BUY
$37.05 - $65.03 $3.36 Million - $5.89 Million
90,580 Added 7.17%
1,353,077 $80.8 Million
Q1 2020

May 14, 2020

BUY
$33.63 - $69.4 $160,953 - $332,148
4,786 Added 0.38%
1,262,497 $52 Million
Q4 2019

Feb 18, 2020

SELL
$31.7 - $69.93 $2.77 Million - $6.11 Million
-87,313 Reduced 6.49%
1,257,711 $78.3 Million
Q3 2019

Nov 14, 2019

BUY
$19.95 - $38.85 $26.3 Million - $51.2 Million
1,318,924 Added 5053.35%
1,345,024 $45.7 Million
Q2 2019

Aug 14, 2019

SELL
$21.05 - $26.21 $10.5 Million - $13 Million
-496,781 Reduced 95.01%
26,100 $589,000
Q1 2019

May 14, 2019

SELL
$20.65 - $29.55 $1.99 Million - $2.85 Million
-96,437 Reduced 15.57%
522,881 $12.1 Million
Q4 2018

Feb 13, 2019

BUY
$19.08 - $36.14 $665,911 - $1.26 Million
34,901 Added 5.97%
619,318 $13 Million
Q3 2018

Nov 08, 2018

BUY
$33.57 - $42.1 $3.65 Million - $4.58 Million
108,871 Added 22.89%
584,417 $22.6 Million
Q2 2018

Aug 13, 2018

BUY
$20.06 - $44.95 $9.54 Million - $21.4 Million
475,546 New
475,546 $18.7 Million
Q1 2018

May 14, 2018

SELL
$20.04 - $29.71 $501,000 - $742,750
-25,000 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$16.54 - $24.2 $413,500 - $605,000
25,000
25,000 $567,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.